The Enterococcus faecalis 30S ribosomal protein S18, often denoted as rpsR, is a component of the 30S ribosomal subunit in E. faecalis. Ribosomes, essential for protein synthesis, are composed of two subunits, and the 30S subunit is crucial for mRNA binding and decoding. The rpsR protein, therefore, plays a vital role in the bacterium’s ability to produce proteins, which are fundamental for its survival and function. Recombinant rpsR implies that the protein is produced using recombinant DNA technology, where the gene encoding rpsR is cloned and expressed in a host organism to produce large quantities of the protein for research or other applications .
The ribosomal protein S18 (Rps18) is a component of the 30S subunit of ribosomes. While its precise function is still under investigation, Rps18 is thought to be involved in the assembly and stabilization of the 30S subunit, as well as in mRNA binding and translation initiation. Modifications or mutations in rpsR can affect ribosomal function and may influence antibiotic resistance or bacterial fitness .
Recombinant production of rpsR involves cloning the rpsR gene from Enterococcus faecalis into a suitable expression vector. This vector is then introduced into a host organism, such as E. coli, which is used as a cellular factory to produce the protein . The recombinant protein can then be purified for downstream applications, such as structural studies, functional assays, or vaccine development .
Recombinant E. faecalis rpsR has several potential applications in research:
Structural Biology: Recombinant rpsR can be used for crystallization and X-ray crystallography to determine its three-dimensional structure, providing insights into its function and interactions with other ribosomal components.
Drug Discovery: RpsR is a potential target for developing new antibiotics. Understanding its structure and function can aid in the design of drugs that specifically inhibit its activity, thereby disrupting bacterial protein synthesis .
Vaccine Development: Ribosomal proteins, including rpsR, have been explored as potential vaccine candidates. Recombinant rpsR can be used to elicit an immune response in animals, providing protection against E. faecalis infections .
Immunological Studies: Recombinant rpsR can be employed to study the immune responses it elicits, as demonstrated in studies involving Lactococcus lactis and Enterococcus faecalis .
Studies have explored the use of recombinant Lactococcus lactis and Enterococcus faecalis expressing certain proteins to evoke immune responses. For example, recombinant bacteria expressing the Hexon protein of fowl adenovirus 4 (FAdV) have been developed as potential vaccines . Chickens immunized with these recombinant bacteria showed significant specific responses, indicating that live recombinant bacteria can stimulate immune responses .
In these studies, E. faecalis strains expressing specific proteins induced more robust immune responses compared to L. lactis strains . This suggests that E. faecalis may have a unique ability to stimulate the immune system, possibly due to its colonization characteristics or other factors .
Recombinase-based in vivo expression technology (RIVET) has been used to identify promoters on the E. faecalis chromosome that are specifically activated during infection . This technology helps in identifying genes, including those coding for antisense RNAs, that are expressed during infection, providing insights into the bacterium's adaptation mechanisms .
Enterococcus faecalis is known for its increasing antibiotic resistance, which poses a significant clinical challenge . Ribosomal proteins, including rpsR, can play a role in antibiotic resistance. Mutations in rpsR or other ribosomal protein genes can confer resistance to antibiotics that target the ribosome . For instance, alterations in ribosomal proteins can affect the binding affinity of antibiotics, leading to reduced drug efficacy .
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes. We will accommodate your request whenever possible.
Note: Standard shipping includes blue ice packs. For dry ice shipping, please contact us in advance; additional charges will apply.
The tag type will be determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Binds as a heterodimer with protein S6 to the central domain of the 16S rRNA, contributing to the stabilization of the 30S ribosomal subunit platform.
KEGG: efa:EF0009
STRING: 226185.EF0009
Enterococcus faecalis 30S ribosomal protein S18 (rpsR) is a small ribosomal protein component of the 30S small subunit, essential for proper ribosome assembly and translation. Based on related ribosomal protein research:
S18 consists of approximately 152 amino acids with a molecular weight of approximately 17.7 kDa (extrapolated from rat S18 data)
Functions as part of the small ribosomal subunit, contributing to mRNA binding and translation fidelity
Has structural homology with bacterial S18 proteins across species, with significant conservation between gram-positive bacteria
Post-translationally modified by N-terminal acetylation via RimI acetyltransferase
Experimental approach for structural characterization:
Recombinant expression with His-tag in E. coli expression systems
Purification using affinity chromatography
Structural analysis using X-ray crystallography or cryo-EM in complex with other ribosomal components
For optimal recombinant expression of E. faecalis S18 protein:
E. coli-based expression systems are most commonly employed, with considerations for:
Vector selection: pET-series vectors with T7 promoter systems provide high expression levels
Host strain selection: BL21(DE3) or derivatives optimized for recombinant protein expression
Inclusion of appropriate affinity tags (His-tag being most common) for purification
Codon optimization for E. coli expression, especially when gram-positive genes are expressed in gram-negative hosts
Expression methodology:
Clone the rpsR gene into expression vector with appropriate tags (typically N-terminal His-tag)
Transform into expression host cells
Induce protein expression with IPTG (typically 0.5-1.0 mM)
Culture at lower temperatures (16-25°C) post-induction to enhance solubility
Harvest cells and extract protein using standardized lysis procedures
Signal peptide considerations:
Signal peptides can significantly impact secretion efficiency for recombinant proteins
Bioinformatic tools such as SignalP, Phobius, and PrediSi can be used to predict optimal signal peptides
For cytoplasmic expression of S18, signal peptides are typically unnecessary
Post-translational modifications, particularly N-terminal acetylation by RimI acetyltransferase, are critical for S18 function. Methods for analysis include:
Mass spectrometry approaches:
MALDI-MS for determination of intact mass differences (acetyl group adds 42 Da)
LC-MS/MS for peptide-level analysis of modifications
Sample preparation involving trypsin digestion followed by enrichment of acetylated peptides
Comparative analysis methodology between wild-type and modified S18:
Express recombinant S18 in both wild-type and RimI-knockout strains
Extract and purify the protein using affinity chromatography
Analyze by mass spectrometry to detect mass differences
Data from RimI knockout studies demonstrate:
S18 from RimI knockout strains shows mass reduction precisely equal to an acetyl group
Complementation with plasmid-encoded RimI restores acetylation
Growth defects are observed in RimI knockout strains, particularly in minimal media conditions
S18 and other ribosomal proteins contribute to antibiotic resistance in E. faecalis through several mechanisms:
Ribosomal protection mechanisms:
Structural modifications of the ribosome can affect binding of antibiotics that target the 30S subunit
Mutations in ribosomal proteins like S18 may alter ribosome conformation and reduce antibiotic binding affinity
Research findings on tetracycline-class antibiotics resistance:
Omadacycline resistance involves ribosomal proteins and potential mutations in 30S subunit genes
Heteroresistance can develop without mutations in 30S ribosomal subunit genes but may involve overexpression of ABC transporter proteins
Experimental methodology for investigating S18's role in resistance:
Generate site-directed mutations in the rpsR gene
Express in susceptible strains and measure MIC values
Perform ribosome binding assays with fluorescently-labeled antibiotics
Use cryo-EM to visualize structural changes in ribosomes containing mutated S18
MIC data from clinical isolates of E. faecalis against tetracycline-class antibiotics:
| Antibiotic | MIC Range (mg/L) | MIC50/90 (mg/L) |
|---|---|---|
| Omadacycline | 0.06-1.0 | 0.5/1.0 |
| Doxycycline | Not specified | 16/32 |
| Minocycline | Not specified | 16/32 |
Data derived from 276 clinical isolates collected in China (2011-2015)
N-terminal acetylation of S18 by RimI acetyltransferase significantly impacts E. faecalis fitness:
Functional impacts:
Acetylation affects protein stability, interaction capabilities, and possibly ribosomal assembly
RimI acetylates both S18 and elongation factor Tu (EF-Tu), suggesting coordinated regulation of translation machinery
Experimental evidence from growth studies:
RimI knockout strains (ΔrimI) show growth disadvantages compared to wild-type strains
Growth defects are moderate in rich media (LB) but more pronounced in minimal media
Competition assays demonstrate that acetylation provides a selective advantage
Methodological approach for investigating acetylation effects:
Generate RimI knockout strains (ΔrimI)
Complement with plasmid-encoded RimI (ΔrimI/pIB166::rimI)
Compare growth rates in different media conditions
Perform competition assays between wild-type and knockout strains
Optimal experimental designs for S18 mutation studies include:
Genetic manipulation approaches:
Allelic replacement strategies using temperature-sensitive plasmids like pJRS233
CRISPR-Cas9 systems for precise genome editing
Complementation studies using shuttle vectors (e.g., pIB166)
Structural biology methods:
Cryo-EM of mutant ribosomes to visualize structural changes
Ribosome profiling to assess translation impacts
Polysome profiling to evaluate ribosome assembly and function
Workflow for comprehensive mutation analysis:
Generate precise mutations in rpsR using PCR-based site-directed mutagenesis
Introduce mutations into the chromosome using allelic replacement
Verify mutations by sequencing
Assess growth phenotypes under various conditions
Perform ribosome isolation and functional assays
Important considerations from related research:
Design controls carefully, including empty vector controls
Include complementation strains to confirm phenotypes are due to specific mutations
Certain ribosomal protein mutations may confer growth defects or temperature sensitivity
Consider effects on both translation accuracy and efficiency
Quantitative proteomics offers powerful tools for analyzing S18 expression and interactions:
Methodological options:
Tandem Mass Tag (TMT) labeling coupled with nano-LC-MS/MS for comparative quantitation
Stable Isotope Labeling with Amino acids in Cell culture (SILAC) for metabolic labeling
Label-free quantification for simpler experimental designs
Protocol for membrane protein isolation and analysis (applicable to ribosomal studies):
Harvest bacterial cells at mid-exponential phase
Lyse cells by ultrasonication in appropriate buffer with protease inhibitors
Perform ultracentrifugation to isolate membrane fractions
Quantitate using Bradford assay and verify by SDS-PAGE
Process samples for proteomics analysis using TMT-labeling
Data processing and analysis:
Apply false discovery rate (FDR) cutoff (typically 1%)
Use statistical significance threshold (p < 0.05)
Compare expression levels between experimental conditions
Validate findings using complementary techniques (e.g., western blotting)
ClpP protease significantly influences S18 abundance and impacts antimicrobial tolerance:
Key research findings:
ClpP deletion (ΔclpP) decreases the abundance of multiple ribosomal proteins, including S18 (rpsR)
These changes are linked to altered stress tolerance and biofilm formation
The ΔclpP mutant shows modified antimicrobial susceptibility profiles
Experimental approach to investigate this relationship:
Generate ClpP deletion mutant using temperature-sensitive plasmid (pJRS233)
Create complemented strain (ΔclpP/pIB166::clpP)
Perform quantitative proteomics to measure ribosomal protein levels
Assess biofilm formation capacity
Determine antimicrobial susceptibility profiles
Conduct virulence testing using Galleria mellonella infection model
Virulence data from G. mellonella infection model:
| Strain | Survival rate at 72h p.i. |
|---|---|
| Wild-type | 70.0% (28/40) |
| ΔclpP mutant | 37.5% (15/40) |
| ΔclpP/pIB166::clpP | 57.5% (23/40) |
Statistical significance: p < 0.01 between wild-type and ΔclpP mutant (log-rank test)
S18 plays a critical role in RNA binding within the ribosome. Techniques to study these interactions include:
Grad-seq methodology for comprehensive RNA-protein interaction mapping:
Prepare bacterial lysates from cultures grown to desired phase
Fractionate using glycerol gradient ultracentrifugation
Collect fractions and analyze RNA and protein content
Perform sequencing and mass spectrometry on fractions
Create sedimentation profiles of RNAs and proteins
RNA immunoprecipitation sequencing (RIP-seq) approach:
Express tagged S18 protein
Cross-link RNA-protein complexes in vivo
Lyse cells and perform immunoprecipitation
Extract and sequence bound RNAs
Data visualization and analysis:
Create browser resources for interactive searching of sedimentation profiles
Perform unsupervised clustering of RNA and protein profiles
Identify clusters representing functional complexes
Investigating S18's role in pathogenicity requires multiple complementary approaches:
Infection models:
Galleria mellonella larval infection model provides rapid assessment of virulence
Mouse infection models for systemic infections, endocarditis, or UTI studies
Cell culture models to assess bacterial adhesion, invasion, and intracellular survival
Experimental design framework:
Generate S18 mutant strains (point mutations or expression level modifications)
Assess in vitro phenotypes (growth, biofilm formation, stress tolerance)
Determine antimicrobial susceptibility profiles
Evaluate virulence in appropriate infection models
Measure inflammatory responses and immune evasion capabilities
Dual nature of E. faecalis as commensal and pathogen:
As a commensal, E. faecalis produces vitamins, metabolizes nutrients, and maintains intestinal pH
As a pathogen, it can cause serious infections when it spreads beyond the intestine
S18 and other ribosomal proteins may play roles in adaptation between these states
| Infection types | Risk factors | Associated virulence factors |
|---|---|---|
| UTIs | Catheterization | Biofilm formation, antibiotic resistance |
| Bacteremia | Immunosuppression | Surface proteins, cytolysin |
| Endocarditis | Heart valve damage | Aggregation substance, adhesins |
| Wound infections | Surgical procedures | Gelatinase, biofilm formation |